CIK 0001590750 · Large accelerated filer
Viridian Therapeutics, Inc.\DE
Sign in to watch- Ticker
- VRDN
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 471187261
- Phone
- 617.272.4600
- Business address
- 221 CRESCENT STREET, SUITE 103A, WALTHAM, MA, 02453
- Former names
- MIRAGEN THERAPEUTICS, INC., SIGNAL GENETICS, INC., SIGNAL GENETICS LLC
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Regulation FD disclosure · Other events
- 8-K Event Shareholder vote results
- 8-K Event Agreement ended
- 8-K Event Material agreement
- 8-K Event Material agreement · New debt or obligation · Other events
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- DEF 14A Proxy Proxy Statement
- 8-K Event Regulation FD disclosure
- 10-K Report Annual Report
- 8-K Event Results of operations
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Material agreement
- 8-K Event Results of operations
- 8-K Event Material agreement · Regulation FD disclosure
Page 1 of 11 · 206 filings